ABB India has informed that it enclosed a copy of Press Release, titled ‘ABB drives enhance safety and energy efficiency at Bharat Biotech's Covaxin manufacturing facility’, which is being issued by the Company today to the media, for the information of the Stock Exchanges, as required under the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.